Key features and details
- Rabbit polyclonal to SAP30BP
- Suitable for: ICC/IF, IHC-P, WB
- Reacts with: Human
- Isotype: IgG
Product nameAnti-SAP30BP antibody
See all SAP30BP primary antibodies
DescriptionRabbit polyclonal to SAP30BP
Tested applicationsSuitable for: ICC/IF, IHC-P, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
- Human kidney tissue. MCF7 cells. LY415705 cell lysate.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 40% Glycerol, 59% PBS
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab204320 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ICC/IF||Use a concentration of 0.25 - 2 µg/ml.|
|IHC-P||1/200 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.|
|WB||Use a concentration of 0.04 - 0.4 µg/ml. Predicted molecular weight: 34 kDa.|
FunctionInduces cell death. May act as a transcriptional corepressor of a gene related to cell survival. May be involved in the regulation of beta-2-microglobulin genes.
Sequence similaritiesBelongs to the HCNGP family.
- Information by UniProt
- HCNGP antibody
- HSV 1 binding antibody
- HSV-1 binding transcriptional regulator protein antibody
Immunofluorescent analysis of MCF7 cells (PFA-fixed/Triton X-100 permeabilized) labeling SAP30BP with ab204320 at 4 µg/ml.
Immunohistochemical analysis of paraffin-embedded Human kidney tissue, labeling SAP30BP with ab204320 at 1/200 dilution.
All lanes : Anti-SAP30BP antibody (ab204320) at 1/100 dilution
Lane 1 : Negative Control
Lane 2 : LY415705 cell lysate
Developed using the ECL technique.
Predicted band size: 34 kDa
ab204320 has not yet been referenced specifically in any publications.